Simple view
Full metadata view
Authors
Statistics
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia : a phase 1/2a study
Journal
The Lancet. Haematology
200
Author
Volume
6
Issue
2
Pages
e67-e78
ISSN
2451-9960
eISSN
2352-3026
Language
English
Journal language
English
Affiliation
Wydział Lekarski : Klinika Hematologii
Scopus© citations
156
dc.affiliation | Wydział Lekarski : Klinika Hematologii | pl |
dc.cm.date | 2020-01-07 | |
dc.cm.id | 92953 | |
dc.contributor.author | Younes, Anas | pl |
dc.contributor.author | Brody, Joshua | pl |
dc.contributor.author | Carpio, Cecilia | pl |
dc.contributor.author | Lopez-Guillermo, Armando | pl |
dc.contributor.author | Ben-Yehuda, Dina | pl |
dc.contributor.author | Ferhanoglu, Burhan | pl |
dc.contributor.author | Nagler, Arnon | pl |
dc.contributor.author | Ozcan, Muhit | pl |
dc.contributor.author | Avivi, Irit | pl |
dc.contributor.author | Bosch, Francesc | pl |
dc.contributor.author | Caballero Barrigon, Maria Dolores | pl |
dc.contributor.author | Hellman, Andrzej | pl |
dc.contributor.author | Kuss, Bryone | pl |
dc.contributor.author | Ma, David D.F. | pl |
dc.contributor.author | Demirkan, Fatih | pl |
dc.contributor.author | Yagci, Munci | pl |
dc.contributor.author | Horowitz, Netanel A. | pl |
dc.contributor.author | Marlton, Paula | pl |
dc.contributor.author | Cordoba, Raul | pl |
dc.contributor.author | Wróbel, Tomasz P. | pl |
dc.contributor.author | Buglio, Daniela | pl |
dc.contributor.author | Streit, Michael | pl |
dc.contributor.author | Hodkinson, Brendan P. | pl |
dc.contributor.author | Schaffer, Michael | pl |
dc.contributor.author | Alvarez, John | pl |
dc.contributor.author | Ceulemans, Rob | pl |
dc.contributor.author | Balasubramanian, Sriram | pl |
dc.contributor.author | de Jong, Jan | pl |
dc.contributor.author | Wang, Shean-sheng | pl |
dc.contributor.author | Fourneau, Nele | pl |
dc.contributor.author | Jurczak, Wojciech - 129923 | pl |
dc.date.accessioned | 2020-01-17T10:06:39Z | |
dc.date.available | 2020-01-17T10:06:39Z | |
dc.date.issued | 2019 | pl |
dc.description.number | 2 | pl |
dc.description.physical | e67-e78 | pl |
dc.description.points | 200 | pl |
dc.description.volume | 6 | pl |
dc.identifier.doi | 10.1016/S2352-3026(18)30217-5 | pl |
dc.identifier.eissn | 2352-3026 | |
dc.identifier.issn | 2451-9960 | pl |
dc.identifier.project | ROD UJ / O | pl |
dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/145340 | |
dc.language | eng | pl |
dc.language.container | eng | pl |
dc.rights | Dodaję tylko opis bibliograficzny | * |
dc.rights.licence | bez licencji | |
dc.subtype | Article | pl |
dc.title | Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia : a phase 1/2a study | pl |
dc.title.journal | The Lancet. Haematology | pl |
dc.type | JournalArticle | pl |
dspace.entity.type | Publication |
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii dc.cm.date
2020-01-07 dc.cm.id
92953 dc.contributor.authorpl
Younes, Anas dc.contributor.authorpl
Brody, Joshua dc.contributor.authorpl
Carpio, Cecilia dc.contributor.authorpl
Lopez-Guillermo, Armando dc.contributor.authorpl
Ben-Yehuda, Dina dc.contributor.authorpl
Ferhanoglu, Burhan dc.contributor.authorpl
Nagler, Arnon dc.contributor.authorpl
Ozcan, Muhit dc.contributor.authorpl
Avivi, Irit dc.contributor.authorpl
Bosch, Francesc dc.contributor.authorpl
Caballero Barrigon, Maria Dolores dc.contributor.authorpl
Hellman, Andrzej dc.contributor.authorpl
Kuss, Bryone dc.contributor.authorpl
Ma, David D.F. dc.contributor.authorpl
Demirkan, Fatih dc.contributor.authorpl
Yagci, Munci dc.contributor.authorpl
Horowitz, Netanel A. dc.contributor.authorpl
Marlton, Paula dc.contributor.authorpl
Cordoba, Raul dc.contributor.authorpl
Wróbel, Tomasz P. dc.contributor.authorpl
Buglio, Daniela dc.contributor.authorpl
Streit, Michael dc.contributor.authorpl
Hodkinson, Brendan P. dc.contributor.authorpl
Schaffer, Michael dc.contributor.authorpl
Alvarez, John dc.contributor.authorpl
Ceulemans, Rob dc.contributor.authorpl
Balasubramanian, Sriram dc.contributor.authorpl
de Jong, Jan dc.contributor.authorpl
Wang, Shean-sheng dc.contributor.authorpl
Fourneau, Nele dc.contributor.authorpl
Jurczak, Wojciech - 129923 dc.date.accessioned
2020-01-17T10:06:39Z dc.date.available
2020-01-17T10:06:39Z dc.date.issuedpl
2019 dc.description.numberpl
2 dc.description.physicalpl
e67-e78 dc.description.pointspl
200 dc.description.volumepl
6 dc.identifier.doipl
10.1016/S2352-3026(18)30217-5 dc.identifier.eissn
2352-3026 dc.identifier.issnpl
2451-9960 dc.identifier.projectpl
ROD UJ / O dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/145340 dc.languagepl
eng dc.language.containerpl
eng dc.rights*
Dodaję tylko opis bibliograficzny dc.rights.licence
bez licencji dc.subtypepl
Article dc.titlepl
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia : a phase 1/2a study dc.title.journalpl
The Lancet. Haematology dc.typepl
JournalArticle dspace.entity.type
Publication Affiliations
Wydział Lekarski
Jurczak, Wojciech
No affiliation
Younes, Anas
Brody, Joshua
Carpio, Cecilia
Lopez-Guillermo, Armando
Ben-Yehuda, Dina
Ferhanoglu, Burhan
Nagler, Arnon
Ozcan, Muhit
Avivi, Irit
Bosch, Francesc
Caballero Barrigon, Maria Dolores
Hellman, Andrzej
Kuss, Bryone
Ma, David D.F.
Demirkan, Fatih
Yagci, Munci
Horowitz, Netanel A.
Marlton, Paula
Cordoba, Raul
Wróbel, Tomasz P.
Buglio, Daniela
Streit, Michael
Hodkinson, Brendan P.
Schaffer, Michael
Alvarez, John
Ceulemans, Rob
Balasubramanian, Sriram
de Jong, Jan
Wang, Shean-sheng
Fourneau, Nele
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
13
Views per month
Views per city
Chandler
2
Wroclaw
2
Ashburn
1
Des Moines
1
Dublin
1
No access
No Thumbnail Available